Sexually Transmitted Diseases (STDS)


  • Benefit to Women not Enough to Convince Men to Get HPV Vaccine
    Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new ...More
    June 2, 2009
    Posted in News
  • Nanotechnology Holds Promise for STD Drug Delivery
    Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs — small interfering RNA (siRNA) molecules that silence genes — the first step in development of a new kind of treatment for sexually transmitted diseases ...More
    May 4, 2009
    Posted in News
  • Researchers Design Method to Induce Immunity to Certain STDs
    Chlamydia trachomatis is the most common bacterial agent of sexually transmitted disease, accounting for more than a million reported infections in the United States each year. Researchers at the California NanoSystems Institute (CNSI) at UCLA and the David Geffen School of ...More
    April 30, 2009
    Posted in News
  • Vaccines Are for Adults, Too: Are Your Shots Up to Date?
    Routine vaccination of children has helped eliminate or greatly reduce many devastating illnesses, including measles, polio, whooping cough and diphtheria. But vaccinations are not just for children, they’re for adults, too. For some adults, the news that they need to ...More
    April 28, 2009
    Posted in News
  • Partner Behavior Better Predicts STD Risks
    Risky behaviors such as not using condoms or having sex with multiple people put young adults at risk for contracting sexually transmitted diseases (STDs), but perhaps not as much as the characteristics of their sexual partners, University of Florida researchers say.The ...More
    April 6, 2009
    Posted in News
  • Clinical Trial Finds Microbicide Promising as HIV Prevention Method for Women
    A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. According to findings presented at the Conference on Retroviruses and ...More
    March 5, 2009
    Posted in News
  • Anti-HIV Gel Shows Promise in Large-Scale Study in Women
    An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States. Findings of the recently concluded study, funded by the National Institute of Allergy and ...More
    February 9, 2009
    Posted in News
  • Nanoemulsion Potent Against Superbugs Killing Cystic Fibrosis Patients
    University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.Cystic ...More
    February 4, 2009
    Posted in News, PPE & Standard Precautions
  • CDC Report Finds High Burden of Sexually Transmitted Diseases
    Reported cases of chlamydia and gonorrhea in the United States exceeded 1.4 million in 2007, according to an annual report by the Centers for Disease Control and Prevention (CDC). These diseases continue to be the most commonly reported infectious diseases in the ...More
    January 13, 2009
    Posted in News
  • Herpes Drug Inhibits HIV Replication, but With a Price
    The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. This beneficial effect does pose a risk though, as HIV-infected cells treated with acyclovir promote the ...More
    November 6, 2008
    Posted in News